L

LTR Pharma Ltd
ASX:LTP

Watchlist Manager
LTR Pharma Ltd
ASX:LTP
Watchlist
Price: 0.725 AUD -4.61% Market Closed
Market Cap: 111.5m AUD
Have any thoughts about
LTR Pharma Ltd?
Write Note

LTR Pharma Ltd
Effect of Foreign Exchange Rates

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

LTR Pharma Ltd
Effect of Foreign Exchange Rates Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Effect of Foreign Exchange Rates CAGR 3Y CAGR 5Y CAGR 10Y
L
LTR Pharma Ltd
ASX:LTP
Effect of Foreign Exchange Rates
-AU$27.9k
CAGR 3-Years
-114%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Mayne Pharma Group Ltd
ASX:MYX
Effect of Foreign Exchange Rates
-AU$847k
CAGR 3-Years
54%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Neuren Pharmaceuticals Ltd
ASX:NEU
Effect of Foreign Exchange Rates
AU$3.8m
CAGR 3-Years
N/A
CAGR 5-Years
41%
CAGR 10-Years
N/A
Botanix Pharmaceuticals Ltd
ASX:BOT
Effect of Foreign Exchange Rates
AU$86.2k
CAGR 3-Years
96%
CAGR 5-Years
27%
CAGR 10-Years
N/A
Probiotec Ltd
ASX:PBP
Effect of Foreign Exchange Rates
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Arovella Therapeutics Ltd
ASX:ALA
Effect of Foreign Exchange Rates
AU$23k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

LTR Pharma Ltd
Glance View

Market Cap
101.1m AUD
Industry
Pharmaceuticals

LTR Pharma Ltd is a AU-based company operating in Pharmaceuticals industry. The company is headquartered in Brisbane, Queensland. The company went IPO on 2023-12-11. LTR Pharma Limited is an Australia-based clinical-stage biopharmaceutical company. The firm is focused on holistically improving men’s health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction (ED). Its lead product SPONTAN is set apart from existing ED therapies by its mechanism of action-intranasal delivery technology of a PDE5 inhibitor. The nasal cavity is a highly vascular part of the body supporting even and rapid absorption of the drug, empowering it to work in 10 minutes or less. SPONTAN (SDS-089) is a novel intranasal drug (PDE5) delivery platform for Erectile Dysfunction.

LTP Intrinsic Value
0.008 AUD
Overvaluation 99%
Intrinsic Value
Price
L

See Also

What is LTR Pharma Ltd's Effect of Foreign Exchange Rates?
Effect of Foreign Exchange Rates
-27.9k AUD

Based on the financial report for Jun 30, 2024, LTR Pharma Ltd's Effect of Foreign Exchange Rates amounts to -27.9k AUD.

What is LTR Pharma Ltd's Effect of Foreign Exchange Rates growth rate?
Effect of Foreign Exchange Rates CAGR 3Y
-114%

Over the last year, the Effect of Foreign Exchange Rates growth was -18%. The average annual Effect of Foreign Exchange Rates growth rates for LTR Pharma Ltd have been -114% over the past three years .

Back to Top